首页> 外文学位 >The application of porous adsorbents to increase the dissolution rate of low solubility drugs.
【24h】

The application of porous adsorbents to increase the dissolution rate of low solubility drugs.

机译:多孔吸附剂的应用可提高低溶解度药物的溶解速度。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this research was to further the understanding of the crystalline to amorphous phase transitions that occur when some crystalline drugs are physically mixed with porous adsorbents. This phenomenon may provide a convenient means of enhancing the bioavailability of some poorly soluble drugs that exhibit dissolution-rate limited absorption. Indomethacin (IMC), a high permeability and low solubility drug, was used as a model drug. Three different grades of silica gel (SG) having different pore sizes and surface areas were used as the porous adsorbent. DSC and XRPD analysis showed that the loss in IMC crystallinity, or amorphization of IMC occurs rapidly during the mixing process and was found to occur within 5 minutes. Amorphization was also found to be independent of mixing intensity and time under the experimental conditions studied. The extent of amorphization is dependent upon the IMC/SG ratio, the particle size of IMC and SG and the amount of moisture in SG. The extent of amorphization in the mixtures increased as the ratio of IMC to SG decreased and as the IMC particle size decreased. The extent of amorphization was not highly dependent on the SG surface area or pore size since the bulk of the SG surface area is contained within the pore structure, and is only partially available to crystalline IMC. Blocking the H-bonding silanol groups on SG by chemical modification significantly reduced the extent of amorphization of crystalline IMC. This indicated that the amorphization of crystalline IMC in mixtures with SG occurs as a result of H-bonding between IMC and the silanol groups on the surface of SG. IMC/SG mixtures showed improved dissolution compared to pure crystalline IMC. The improvement in dissolution was directly related to the amount of amorphous IMC in the mixture. IMC/SG mixtures stored at room temperature and under desiccation are physically and chemically stable up to 4 months. To maintain the physical/chemical stability and improved dissolution performance, IMC/SG mixtures should be stored protected from heat, humidity and light. This work has demonstrated the potential of using SG as a means to induce amorphization of crystalline, sparingly soluble drugs such as IMC and to improve in-vitro dissolution.
机译:这项研究的目的是进一步理解当某些结晶药物与多孔吸附剂物理混合时发生的结晶至无定形相变。这种现象可以提供一种方便的手段,以提高某些溶解度有限的吸收性差的难溶性药物的生物利用度。消炎痛(IMC),一种高渗透性和低溶解度的药物,被用作模型药物。具有不同孔径和表面积的三种不同等级的硅胶(SG)被用作多孔吸附剂。 DSC和XRPD分析表明,IMC结晶度的损失或IMC的非晶化在混合过程中迅速发生,并且发现在5分钟内发生。在研究的实验条件下,非晶化也与混合强度和时间无关。非晶化程度取决于IMC / SG比,IMC和SG的粒径以及SG中的水分含量。混合物中非晶化程度随着IMC与SG的比例降低以及IMC粒度降低而增加。非晶化程度并不高度依赖于SG表面积或孔尺寸,因为大部分SG表面积包含在孔结构内,并且仅部分可用于结晶IMC。通过化学修饰封闭SG上的H键合硅烷醇基团可显着降低结晶IMC的非晶化程度。这表明与SG的混合物中结晶IMC的非晶化是由于IMC和SG表面上的硅烷醇基之间的H键而发生的。与纯结晶IMC相比,IMC / SG混合物显示出更好的溶解性。溶解度的提高与混合物中无定形IMC的量直接相关。在室温和干燥条件下储存的IMC / SG混合物在物理和化学上稳定长达4个月。为了保持物理/化学稳定性和改善的溶解性能,应将IMC / SG混合物存放在远离热,湿和光的地方。这项工作证明了将SG用作诱导结晶性微溶性药物(如IMC)非晶化并改善体外溶出度的潜力。

著录项

  • 作者

    Pan, Xiaohong.;

  • 作者单位

    University of Maryland, Baltimore.;

  • 授予单位 University of Maryland, Baltimore.;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 110 p.
  • 总页数 110
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药剂学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号